(Finance) – Pharmacosma company listed since March 2022 on Euronext Growth Milan and active in the Health, Pharma & Beauty sector, announced that Paolo Cimmino and the new Investor Relations Manager in place of the managing director Fabio de Concilio. Cimmino was appointed CFO on 2 May with the aim of boosting the company’s managerialization process. In this way, the CEO will be able to devote more energy to the growth process of the company, which is intended to be expressed through internal and external lines, reads a note.
“The appointment of Paolo Cimmino as Investor Relations Manager confirms the path taken by Farmacosmo to manage the company through the inclusion in key roles of professionally qualified figures with proven experience – commented Fabio de Concilio – Paolo, as CFO, is already contributing significantly to the growth and development of Farmacosmo and his appointment as Investor Relations Manager it will be relevant to further support the rapid growth path undertaken by Farmacosmo “.